Terns Pharmaceuticals Inc (TERN)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
CEO:
Senthil Sundaram
Employees:
30
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY, CA 94404
650-525-5535 EXT.101

We are a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Our programs are based on clinically-validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients.

Data derived from most recent annual or quarterly report
Market Cap 235.223 Million Shares Outstanding25.131 Million Avg 30-day Volume 40.605 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 28.36 / 6.92 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million

Are you looking for this stock instead?

View recent insider trading info

Funds Holding TERN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TERN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FELLOWS DAVID A

  • Director
22,000 2021-09-28 1

KINDLER JEFFREY B

  • Director
22,000 2021-09-28 1

YOON SEOKHO BRYAN COO AND GENERAL COUNSEL

  • Officer
120,000 2021-09-28 1

SUNDARAM SENTHIL VEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
315,000 2021-09-28 1

VIGNOLA MARK J. CHIEF FINANCIAL OFFICER

  • Officer
120,000 2021-09-28 1

QUIGLEY JILL M.

  • Director
22,000 2021-09-28 1

QUIRK ERIN PRESIDENT AND CMO

  • Officer
142,500 2021-09-28 1

TAYLOR ANN ELIZABETH

  • Director
0 2021-09-28 2

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FELLOWS DAVID A - Director

2021-09-30 21:09:59 -0400 2021-09-28 A 22,000 a 22,000 direct

QUIGLEY JILL M. - Director

2021-09-30 21:11:27 -0400 2021-09-28 A 22,000 a 22,000 direct

YOON SEOKHO BRYAN - Officer COO AND GENERAL COUNSEL

2021-09-30 21:17:51 -0400 2021-09-28 A 120,000 a 120,000 direct

TAYLOR ANN ELIZABETH - Director

2021-10-12 21:20:52 -0400 2021-09-28 A 44,000 a 44,000 direct

VIGNOLA MARK J. - Officer CHIEF FINANCIAL OFFICER

2021-09-30 21:17:32 -0400 2021-09-28 A 120,000 a 120,000 direct

KINDLER JEFFREY B - Director

2021-09-30 21:17:08 -0400 2021-09-28 A 22,000 a 22,000 direct

QUIRK ERIN - Officer PRESIDENT AND CMO

2021-09-30 21:14:45 -0400 2021-09-28 A 142,500 a 142,500 direct

SUNDARAM SENTHIL VEL - Director - Officer CHIEF EXECUTIVE OFFICER

2021-09-30 21:13:44 -0400 2021-09-28 A 315,000 a 315,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TERNS PHARMACEUTICALS INC TERN 2021-10-25 16:45:02 UTC -0.7224 0.7924 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-25 16:15:03 UTC -0.7224 0.7924 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-25 15:45:03 UTC -0.7224 0.7924 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-25 15:15:03 UTC -0.7224 0.7924 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-25 14:45:02 UTC -0.7445 0.8145 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-25 14:15:03 UTC -0.7445 0.8145 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-25 13:45:03 UTC -0.7445 0.8145 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-25 13:15:03 UTC -0.7445 0.8145 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-25 12:45:04 UTC -0.7445 0.8145 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-22 22:15:03 UTC -0.7445 0.8145 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-22 21:45:03 UTC -0.7445 0.8145 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-22 21:15:03 UTC -0.7445 0.8145 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-22 20:45:03 UTC -0.7445 0.8145 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-22 20:15:03 UTC -0.7445 0.8145 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-22 19:45:03 UTC -0.7445 0.8145 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-22 19:15:03 UTC -0.7445 0.8145 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-22 18:45:03 UTC -0.8107 0.8807 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-22 18:15:03 UTC -0.8107 0.8807 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-22 17:45:03 UTC -0.8107 0.8807 40000
TERNS PHARMACEUTICALS INC TERN 2021-10-22 17:15:03 UTC -0.8107 0.8807 40000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments